Stock Splits
By The Online Investor Staff, updated Tue., Dec. 1, 4:31 AM
| This Slide: #10 of 25 |
Slide #10. Intec Pharma Ltd. (NASDAQ:NTEC) — 1 for 20 Reverse Split
Announced:
10/29/2020
Stock Split:
1 for 20
Record Date:
10/29/2020
Pay Date:
10/30/2020
NTEC Optionable?:
Yes
Intec Pharma is a clinical stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill platform technology, which Co. refers to as the Accordion Pill. Co.'s Accordion Pill is an oral drug delivery system that is designed to improve the efficacy and safety of existing drugs and drugs in development by utilizing a gastric retention, and specific release mechanism. Co.'s product pipeline includes several product candidates in various stages of development. Co.'s product candidate, Accordion Pill Carbidopa/Levodopa is being developed for the indication of treatment of Parkinson's disease symptoms in Parkinson's disease patients. 
NTEC Detailed Information Page & Split History »
|
||||||
Open the NTEC Page at The Online Investor (in a new window) »
|
|
Avg. Broker Rec.
 
|
Hold (2.00 out of 4) 100th percentile
(ranked higher than approx. 100% of all stocks covered)
Based on Zacks ABR data; powered by Xignite |
